Dear Investors,

I would like to give everyone an update on how our stocks have performed since we sent them to you!


I am proud to say that ever since we have notified our followers, we have had incredible returns in a few short months:

IPOB, the stock was sitting at $14 and as of today, it sits at $27(100% gain)

Palantir, the stock was sitting at $8 and as of today, it sits at $26.43(235% gain)

Lemonade, the stock was sitting at $48 and as of today, it sits at $90((87% gain)

Bitcoin, the crypto was sitting at $11,500 and as of today, it sits at $19,404 (68.75% gain)

Square, the stock was sitting at $152 and as of today, it sits at $220. (44.75% gain)

These have been the only stocks that we have sent, and I am very glad that everyone has had the chance to make money.

With that being said, you should always have a timeframe for how long you plan on keeping every stock in your portfolio. This time frame, can be one day or it can be 30 years. I plan on holding IPOB, Palantir, and Lemonade through 2025 unless something dramatic happens. I plan on holding bitcoin and square through December 2021 and then re-buying them.

You always want to think of your stocks in terms of % gain, and our goal should be to beat the S%P 500 each year which is around beating 10% each year. Why are they the benchmark? If we can’t beat the 10%, it would be the most logical thing to just buy the S&P 500 Index instead of picking out individual stocks.

I just sent out an alert to our premium subscribers about a penny stock that I am buying. You can find this alert here.

I will be back to our normal Monday newsletter starting this Monday with a FinTech Stock that I have fallen in love with since they announced their SPAC.

Stay Hungry, Stay Foolish,


Matt Allen 

Please note that I am not a financial advisor and this is not investment advice. I own every stock that was mentioned in this newsletter.

There is More Newsletter issues
View All
Jamie Dimon is a Fraud
Facebook's Monday Meltdown
Happy Birthday!
The Hardest Part of Stocks
Elon Musk and Tesla Change The Game
Clover Health Disrupts Health Care